RALYL and neoplasm: In addition to the factors mentioned, it is likely that other SFs identified here as having consistent changes across all tumor types (SNRPB, RNPS1, RBM34, ELAVL1, and RALYL; Fig 2E and 2G) could contribute to tumor-associated splicing events in the analyzed datasets.